Death Reported In Phase II Trial For Astellas/FibroGen’s Oral EPO Candidate
Announcement comes just ahead of an FDA advisory committee meeting to discuss EPO products.
Announcement comes just ahead of an FDA advisory committee meeting to discuss EPO products.